Volume 29, issue 2, February 2022

130 articles in this issue

1. Surgical Societies Must Lead the Way on Addressing Bias and Microaggressions

2. Ford Versus Ferrari: Novel Technologies in the Setting of a Reliable Standard

3. Melanoma Surgery in the Emerging Era of Effective Neoadjuvant Therapy

4. Harnessing the Potential of Combination Immunotherapy and Oncolytic Virotherapy for Solid Tumors

5. Genomic Expression Profiling in Melanoma and the Road to Clinical Practice

6. Effectiveness of SPECT/CT Imaging for Sentinel Node Biopsy Staging of Primary Cutaneous Melanoma and Patient Outcomes

7. ASO Author Reflections: Effectiveness of SPECT/CT Imaging for Sentinel Node Biopsy Staging of Primary Cutaneous Melanoma and Patient Outcomes

8. ASO Visual Abstract: Effectiveness of SPECT/CT Imaging for Sentinel Node Biopsy Staging of Primary Cutaneous Melanoma and Patient Outcomes

9. Surgeon Assessment of the Technical Impact of Neoadjuvant Systemic Therapy on Operable Stage III Melanoma

10. ASO Author Reflections: Adding Value to Multidisciplinary Care by Incorporating Structured Surgeon Survey Assessment of the Effect of Neoadjuvant Therapies on Melanoma Operations

11. ASO Visual Abstract: Surgeon Assessment of the Technical Impact of Neoadjuvant Systemic Therapy on Operable Stage III Melanoma

12. Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience

13. ASO Author Reflections: T-VEC as Salvage for Progression of Locoregionally Metastatic Melanoma After Failure of Immunotherapy

14. ASO Visual Abstract: Talimogene Laherparepvec (T-VEC) for Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: An International Multi-institutional Experience

15. Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection

16. ASO Author Reflections: Adjuvant Therapy for Stage III Melanoma With or Without Completion Lymph Node Dissection

17. Post-Publication Discussion: In Reply

18. Post-Publication Discussion: Invitation for Reply

19. Data-Driven Respectful Discourse in the Society of Surgical Oncology

20. ASO Visual Abstract: Data-Driven Respectful Discourse in the Society of Surgical Oncology

21. Twenty-Five Years of Cancer Follow-Up; Is the Data Worth the Effort?

22. Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates Among US Counties

23. ASO Author Reflections: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates among U.S. Counties

24. ASO Visual Abstract: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates Among U.S. Counties

25. Predicting Colon Cancer-Specific Survival for the Asian Population Using National Cancer Registry Data from Taiwan

26. ASO Author Reflections: Robust Prediction Models for Colon Cancer in Asian Patients

27. HIPEC Trials and the US: A Review and Call to Action

28. Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases

29. ASO Author Reflections: What to Expect After You Resect Diaphragm During CRS/HIPEC

30. Nomogram to Predict Incomplete Cytoreduction for Pseudomyxoma Peritonei

31. The Impact of Histologic Liver Inflammation on Oncology and the Prognosis of Patients Undergoing Hepatectomy for Hepatocellular Carcinoma

32. ASO Author Reflections: Is Histologic Liver Inflammation a Predictor in Patients with Hepatocellular Carcinoma after Hepatectomy?

33. Preventing Futile Liver Resection: A Risk-Based Approach to Surgical Selection in Major Hepatectomy for Colorectal Cancer

34. Anatomic Resection for Hepatocellular Carcinoma: Prognostic Impact Assessed from Recurrence Treatment

35. ASO Author Reflections: Does Anatomic Resection Improve Prognosis for Hepatocellular Carcinoma? Assessment from Recurrence Treatment

36. Prospective Multicenter Interventional Study of Surgical Resection for Liver Metastasis from Gastric Cancer: R0 Resection Rate, and Operative Morbidity and Mortality

37. ASO Visual Abstract: A Prospective Multicenter Interventional Study of Surgical Resection for Liver Metastasis from Gastric Cancer: R0 Resection Rate and Operative Morbidity and Mortality

38. Preoperative FDG-Positive Lymph Nodes Predict the Postoperative Prognosis in Resectable Biliary Tract Cancers

39. ASO Author Reflections: The Feasibility of Preoperative FDG-Positive Lymph Nodes of Resectable Biliary Tract Cancers for Postoperative Prognosis

40. ASO Visual Abstract: Preoperative FDG Positive Lymph Nodes Predict the Postoperative Prognosis in Resectable Biliary Tract Cancers

41. Impact of Bile Duct Tumor Thrombus on the Long-Term Surgical Outcomes of Hepatocellular Carcinoma Patients: A Propensity Score Matching Analysis

42. ASO Author Reflections: Impact of Bile Duct Tumor Thrombus in Hepatocellular Carcinoma—Does it Influence Staging Systems?

43. Extended Right Hepatectomy for Hepatocellular Carcinoma

44. ASO Author Reflections: Thoraco-Abdominal Approach with Phrenotomy for Large Liver Tumor in Close Contact with the Vena Cava and the Hepatocaval Confluence

45. Robotic Resection of Type I Hilar Cholangiocarcinoma with Intrapancreatic Bile Duct Dissection

46. Intrahepatic Glissonean Approach for Laparoscopic Bisegmentectomy 7 and 8 With Root-Side Hepatic Vein Exposure

47. Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes

48. A Cross-Sectional Study of Distress Levels in Patients with Newly Diagnosed Breast Cancer: The Impact of Race, Ethnicity, and Language Preference

49. Diagnostic Criteria for Breast Cancer-Related Lymphedema of the Upper Extremity: The Need for Universal Agreement

50. ASO Author Reflections: Breast Cancer-Related Lymphedema—A Suggested Clinical Pathway for Diagnosis

51. Benefits of Trimodality Therapy Compared with Systemic Therapy Alone in Male Patients with Stage IV Breast Cancer

52. ASO Author Reflection: Trimodality Therapy Offers Survival Advantage in Metastatic Male Breast Cancer

53. Disparities in Breast-Conserving Therapy for Non-Hispanic American Indian/Alaska Native Women Compared with Non-Hispanic White Women

54. ASO Author Reflections: Mastectomy Versus Lumpectomy: Are There Surgical Disparities for Native American Women Compared with White Women?

55. Nipple-Sparing Mastectomy versus Skin-Sparing Mastectomy: Does Saving the Nipple Impact Short- and Long-Term Patient Satisfaction?

56. ASO Visual Abstract: Nipple-Sparing Mastectomy Versus Skin-Sparing Mastectomy—Does Saving the Nipple Have an Impact on Short- and Long-Term Patient Satisfaction?

57. Local Recurrence is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers

58. ASO Author Reflections: Heroic Mastectomy for Chemoresistant Disease: A Complex Decision

59. Incremental Spending Associated with Low-Value Treatments in Older Women with Breast Cancer

60. ASO Author Reflections: Adding up the Costs of Low-Value Breast Cancer Care

61. Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study

62. ASO Author Reflections: Impact of Resection Volume on Risk of Local Recurrence—The OPBC-01/iTOP2 Study

63. ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study

64. Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients

65. ASO Visual Abstract: Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment to Reliably Exclude Residual Cancer in Breast Cancer Patients

66. The Attitudes of Brazilian Breast Surgeons on Axillary Management in Early Breast Cancer—10 Years after the ACOSOG Z0011 Trial First Publication

67. ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery

68. ASO Visual Abstract: The Attitudes of Brazilian Breast Surgeons on Axillary Management in Early Breast Cancer 10 Years After the ACOSOG Z0011 Trial First Publication

69. Predictors for Implant Rupture in Two-Stage Tissue Expander-Based Breast Reconstruction: A Retrospective Cohort Study

70. Dissatisfaction After Post-Mastectomy Breast Reconstruction: A Mixed-Methods Study

71. ASO Author Reflections: Decision Support Tools Are Needed to Address Dissatisfaction Among Women Seeking Post-Mastectomy Breast Reconstruction

72. Is the Capanna Technique a Reliable Method for Revision Surgery after Failure of Previous Limb-Salvage Surgery?

73. Clinical Outcomes of Taiwanese Patients with Resected Oral Cavity Squamous Cell Carcinoma Who Underwent Reconstruction with Free Versus Local Flaps

74. Surgical Case Volume has an Impact on Outcomes for Patients with Lateral Neck Disease in Thyroid Cancer

75. Open Versus Minimally Invasive Radical Hysterectomy in Cervical Cancer: The CIRCOL Group Study

76. ASO Author Reflections: Minimally Invasive Radical Hysterectomy in Cervical Cancer: A Brazilian Multicentric Cohort Study (CIRCOL)

77. ASO Visual Abstract: Open Versus Minimally Invasive Radical Hysterectomy in Cervical Cancer: The CIRCOL Group Study

78. Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management

79. ASO Visual Abstract: Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management

80. Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival

81. ASO Author Reflections: Identifying Rectal Cancer Patients Suitable for Watch-and-Wait

82. ASO Visual Abstract: Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival

83. Identification and Adjudication of Adverse Events Following Rectal Cancer Surgery: Observational Case Series in a Region of Ontario, Canada

84. ASO Author Reflections: Optimizing the Quality of Cancer Surgery—Interrogating Adverse Events for Modifiable Factors in the Preoperative Period

85. Malignant Features in Pretreatment Metastatic Lateral Lymph Nodes in Locally Advanced Low Rectal Cancer Predict Distant Metastases

86. ASO Author Reflection: Lateral Pelvic Lymph Nodes in Rectal Cancer—Not All Are Created Equal

87. ASO Visual Abstract: Malignant Features in Pretreatment Metastatic Lateral Lymph Nodes in Locally Advanced Low Rectal Cancer Predict Distant Metastases

88. Extended En Bloc Reoperation for Recurrent or Persistent Parathyroid Carcinoma: Analysis of 31 Cases in a Single Institute Experience

89. ASO Author Reflections: Extended En Bloc Reoperation: A Potential Curative Operation for Recurrent or Persistent Parathyroid Carcinoma

90. ASO Visual Abstract: Extended En Bloc Reoperation for Recurrent or Persistent Parathyroid Carcinoma—Analysis of 31 Cases in a Single-Institution Experience

91. Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer

92. Early Diagnosis of Anastomotic Leakage After Gastric Cancer Surgery Via Analysis of Inflammatory Factors in Abdominal Drainage

93. Lymph Node Evaluation after Neoadjuvant Chemotherapy for Patients with Gastric Cancer

94. ASO Author Reflections: Number of Examined Lymph Nodes in Gastric Cancer Resection Following Neoadjuvant Chemotherapy

95. ASO Visual Abstract: Lymph Node Evaluation following Neoadjuvant Chemotherapy in Patients with Gastric Cancer

96. Does the Volume-Outcome Association in Pancreas Cancer Surgery Justify Regionalization of Care? A Review of Current Controversies

97. ASO Author Reflections: Understanding the Broader Implications of the Volume–Outcome Impact on Pancreas Cancer Surgery

98. Access Denied: Inequities in Clinical Trial Enrollment for Pancreatic Cancer

99. ASO Author Reflections: Seizing the Momentum to Diversify Cancer Clinical Trial Enrollment

100. ASO Visual Abstract: Access Denied—Inequities in Clinical Trial Enrollment for Pancreatic Cancer

101. Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma

102. ASO Author Reflections: Reconsidering the Treatment Strategy for Resectable Pancreatic Cancer Using a Biomarker-Based Scoring System for Prediction of Early Recurrence

103. ASO Visual Abstract: Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma

104. Imaging Features for Predicting High-Grade Dysplasia or Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Systematic Review and Meta-Analysis

105. ASO Author Reflections: Imaging Predictors of High-Grade Dysplasia or Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Systematic Review and Meta-Analysis

106. Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 Tumors—A Nationwide Experience

107. PET Imaging and Rate of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma

108. ASO Author Reflections: Esophageal Squamous Cell Carcinoma—Still a Conundrum

109. PET-Uptake Reduction into Lymph Nodes After Neoadjuvant Therapy is Highly Predictive of Prognosis for Patients Who have Thoracic Esophageal Squamous Cell Carcinoma Treated with Chemoradiotherapy Plus Esophagectomy

110. The Value of Paratracheal Lymphadenectomy in Esophagectomy for Adenocarcinoma of the Esophagus or Gastroesophageal Junction: A Systematic Review of the Literature

111. ASO Visual Abstract: The Value of Paratracheal Lymphadenectomy in Esophagectomy for Adenocarcinoma of the Esophagus or Gastroesophageal Junction: a Systematic Review of the Literature

112. Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses

113. Significance of Antimicrobial Prophylaxis for the Prevention of Early-Onset Pneumonia After Radical Esophageal Cancer Resection: A Retrospective Analysis of 356 Patients Undergoing Thoracoscopic Esophagectomy

114. ASO Visual Abstract: Significance of Antimicrobial Prophylaxis for Prevention of Early-Onset Pneumonia after Radical Esophageal Cancer Resection: A Retrospective Analysis of 356 Patients Undergoing Thoracoscopic Esophagectomy

115. Uniportal Thoracoscopic Single-Direction Basal Subsegmentectomy (Left S10a+ci): Trans-Inferior-Pulmonary-Ligament Approach

116. Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study

117. ASO Author Reflections: Identifying Modifiable and Non-Modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma

118. ASO Visual Abstract: Identifying Modifiable and Non-Modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study

119. Percutaneous Cementoplasty for the Pelvis in Bone Metastasis: 12-Year Experience

120. Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center

121. ASO Author Reflections: Germline Testing for All Patients With Breast Cancer: Has the Time Finally Come?

122. ASO Visual Abstract: Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center

123. Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome for Patients with Pancreatic Ductal Adenocarcinoma

124. ASO Author Reflections: Lymphocyte-to-monocyte ratio as prognostic biomarker in pancreatic ductal adenocarcinoma

125. ASO Visual Abstract: Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome in Patients with Pancreatic Ductal Adenocarcinoma

126. Clinical Relevance of Gastroesophageal Cancer Associated SNPs for Oncologic Outcome After Curative Surgery

127. ASO Author Reflections: From Susceptibility Loci to Oncologically Relevant SNPs in Upper Gastrointestinal Cancer

128. MiR-744 Functions as an Oncogene Through Direct Binding to c-Fos Promoter and Facilitates Non-small Cell Lung Cancer Progression

129. Comparison of Differential Functional Outcomes After Partial Nephrectomy Between Moderate and High Complex Renal Tumor Evaluated with Diethylenetriamine Pentaacetic Acid Scan: A Propensity Score Matched Analysis

130. Versatility of Retzius-Sparing Prostatectomy: Its Application in Renal Transplant Patient and En-bloc Abdominal-Perineal Resection